Search Results - "Nordgren, Brian K."

Stringent complete response (sCR) in patients (pts) with newly diagnosed multiple myeloma (NDMM) treated with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX) by Jakubowiak, Andrzej J., Griffith, Kent A., Dytfeld, Dominik, Vesole, David H., Jagannath, Sundar, Anderson, Tara B., Nordgren, Brian K., Detweiler-Short, Kristen, Lebovic, Daniel, Stockerl-Goldstein, Keith, Jobkar, Terri L., Wear, Sandra Marija, Al-Zoubi, Ammar, Ahmed, Asra Z., Mietzel, Melissa A, Couriel, Daniel R., Kaminski, Mark Stefan, Hussein, Mohamad A., Yeganegi, Homa, Vij, Ravi

“…Abstract only 8011 Background: Combination treatment (tx) with CFZ, LEN, and DEX (CRd) is well tolerated and highly active in NDMM. In a phase 1/2 study, CRd…”
Get full text

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM) by Jakubowiak, Andrzej J, Dytfeld, Dominik, Jagannath, Sundar, Vesole, David H., Anderson, Tara B., Nordgren, Brian K., Detweiler-Short, Kristen, Lebovic, Daniel, Stockerl-Goldstein, Keith E., Griffith, Kent A., Jobkar, Terri L., Durecki, Diane E, Wear, Sandra M., Ott, Robert F, Al-Zoubi, Ammar, Mietzel, Melissa A, Hussein, M, Couriel, Daniel, Leveque, Joseph A, Vij, Ravi

“…Abstract 631▪▪This icon denotes a clinically relevant abstract In relapsed and/or refractory MM, the combination of carfilzomib (CFZ) with lenalidomide (Len),…”
Get full text

Carfilzomib, Lenalidomide, and Dexamethasone In Newly Diagnosed Multiple Myeloma: Initial Results of Phase I/II MMRC Trial by Jakubowiak, Andrzej J, Dytfeld, Dominik, Jagannath, Sundar, Vesole, David H., Anderson, Tara B., Nordgren, Brian K., Lebovic, Daniel, Stockerl-Goldstein, Keith E., Griffith, Kent A., Hill, Melissa A., Harvey, Colleen K., Dollard, Akari M., Ott, Robert, Kelley, Susan L., Barrickman, Jennifer, Kauffman, Michael, Vij, Ravi

“…Abstract 862 Carfilzomib (Cfz) is a novel, irreversible proteasome inhibitor that has demonstrated promising single-agent activity and favorable toxicity…”
Get full text